NBIX vs VRRM · P/E 45, rev $1.77B vs P/E 5.7, rev $53.1M
Neurocrine Biosciences Inc (NBIX) versus Verra Mobility Corp (VRRM) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Verra Mobility Corp (VRRM) is a information technology services company listed on NASDAQ.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported VRRM revenue for 2026-06-30 was $53.1M. Net income was -$21.4M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. VRRM currently screens at market cap $715.5M and trailing P/E 5.7.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. VRRM currently screens at market cap $715.5M and trailing P/E 5.7.
Not investment advice. Open the NBIX and VRRM stock pages for the full models.
Not investment advice.